Chemical inhibitors of the protein 1190003K10Rik can be employed to discern its functional role within cellular signaling pathways. Staurosporine is one such inhibitor, known for its broad-spectrum inhibition of protein kinases which are crucial for signal transduction. By blocking these kinases, staurosporine can interrupt the signaling pathways essential for the functions of 1190003K10Rik. Another inhibitor, Bisindolylmaleimide I, specifically targets Protein Kinase C (PKC), a kinase family implicated in numerous cellular functions. The inhibition of PKC by Bisindolylmaleimide I can suppress the downstream effects that 1190003K10Rik may have in cellular processes. LY294002 and Wortmannin are inhibitors that act on PI3K, a kinase that participates in a variety of signaling cascades, including those that are potentially modulated by 1190003K10Rik. By impeding PI3K, LY294002 and Wortmannin can disrupt the phosphorylation events necessary for the activation and function of 1190003K10Rik.
Furthermore, the protein 1190003K10Rik may be functionally inhibited through the use of targeted kinase inhibitors such as Rapamycin, PD98059, and U0126. Rapamycin inhibits mTOR, a kinase associated with cell growth and proliferation pathways that 1190003K10Rik may influence. PD98059 and U0126, both MEK inhibitors, impede the MAPK/ERK pathway, a critical signaling route in which 1190003K10Rik could be involved. The p38 MAPK inhibitor, SB203580, can obstruct the kinase's role in stress and inflammatory responses, potentially affecting the activity of 1190003K10Rik. Additionally, SP600125 inhibits JNK, another kinase that responds to cellular stress, which can intersect pathway interactions with 1190003K10Rik. Src family kinases, targeted by inhibitors such as Dasatinib and PP2, are vital in various cellular signaling pathways, and their inhibition can suppress the functional activity of 1190003K10Rik. Lastly, Lapatinib acts upon EGFR/HER2 tyrosine kinases, whose inhibition can influence the signaling pathways involving 1190003K10Rik, leading to a reduction in its functional effects within cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. Inhibition of these kinases can disrupt signaling pathways that 1190003K10Rik is involved in, thereby inhibiting its function. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I specifically inhibits Protein Kinase C (PKC). PKC is involved in various cellular processes that 1190003K10Rik might influence; its inhibition can thereby inhibit 1190003K10Rik's function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K. PI3K is upstream of various signaling pathways, including those that 1190003K10Rik may be involved in. Inhibiting PI3K can result in the functional inhibition of 1190003K10Rik. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in cell growth and proliferation. Since mTOR pathways can intersect with pathways involving 1190003K10Rik, its inhibition can lead to functional inhibition of this protein. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, which is involved in the MAPK/ERK pathway. By inhibiting MEK, the ERK pathway is downregulated, which could lead to the inhibition of 1190003K10Rik's function if it is part of this pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor, functioning similarly to PD98059, it downregulates the ERK pathway, potentially inhibiting 1190003K10Rik function by disrupting the pathways it's involved in. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which is involved in stress and inflammatory responses. The inhibition of p38 MAPK can result in the inhibition of 1190003K10Rik if it plays a role in these responses. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, part of the stress-activated pathway that can intersect with cellular processes involving 1190003K10Rik. Inhibiting JNK can lead to the functional inhibition of 1190003K10Rik. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad inhibitor of Src family tyrosine kinases. Src kinases participate in various signaling pathways that might involve 1190003K10Rik, and their inhibition can lead to the inhibition of 1190003K10Rik. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family kinases, similar to Dasatinib, and can inhibit the function of 1190003K10Rik by disrupting the signaling pathways in which these kinases and 1190003K10Rik are involved. | ||||||